Last reviewed · How we verify
NCT03597607
Evaluation of an Intensive Individualized Smoking Cessation Program Delivered by Pharmacists
NA trial testing Intensive Smoking Cessation Group in Smoking Cessation in 150 participants. Completed in 5 April 2022.
25 September 2020
Quick facts
| Lead sponsor | Memorial University of Newfoundland |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 150 |
| Start date | 18 September 2018 |
| Primary completion | 25 September 2020 |
| Estimated completion | 5 April 2022 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Intensive Smoking Cessation Group
- Abbreviated Smoking Cessation Group
Conditions studied
- Smoking Cessation — all drugs for Smoking Cessation →
- Smoking, Tobacco — all drugs for Smoking, Tobacco →
- Quality of Life — all drugs for Quality of Life →
Sponsor
Memorial University of Newfoundland
Who can join
19 and older, any sex, with Smoking Cessation or Smoking, Tobacco. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aims to look at the efficacy and impact of a pharmacist-led smoking cessation program. It will assess an intensive program and an abbreviated program, with the latter being evaluated for feasibility in community pharmacies. Participants will be in one of two groups: intensive or abbreviated. Smoking abstinence rates, self-efficacy and overall satisfaction will be compared. Additionally, a cost-effectiveness analysis will be executed to determine the feasibility of customized smoking cessation programs in community pharmacies across Newfoundland and Labrador.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03597607
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Smoking Cessation
Currently open trials in the same condition.
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
- NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
- NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
Other Memorial University of Newfoundland trials
Trials by the same sponsor.
- NCT07245173 — Randomized Control Trial Comparing the Incidence of Loop Formation in Colonoscopy Techniques · NA · not yet recruiting
- NCT06714331 — Caffeine and Sodium Bicarbonate Supplementation Effects on Resistance Training Performance · EARLY_PHASE1 · completed
- NCT05425797 — The Virtual BETTER Study · NA · completed
- NCT05534633 — APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies · NA · active not recruiting
- NCT05652842 — Assessing the Impact of Rotational and Shift Work on Sleep, Activity, Energy Balance, and Food Choice in Adults · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03597607 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Memorial University of Newfoundland
- Last refreshed: 27 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03597607.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing